Enhancement of the dissolution rate and gastrointestinal absorption of pranlukast as a model poorly water-soluble drug by grinding with gelatin

被引:32
作者
Chono, Sumio [1 ]
Takeda, Eri [1 ]
Seki, Toshinobu [1 ]
Morimoto, Kazuhiro [1 ]
机构
[1] Hokkaido Pharmaceut Univ, Dept Pharmaceut, Otaru, Hokkaido 0470264, Japan
关键词
gelatin; poorly water-soluble drug; pranlukast; grinding; dissolution rate; gastrointestinal absorption;
D O I
10.1016/j.ijpharm.2007.06.037
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The effect of grinding with gelatin on the dissolution behavior and gastrointestinal absorption of a poorly water-soluble drug was evaluated using the antiasthmatic agent, pranlukast, as a model poorly water-soluble drug. A ground pranlukast-gelatin mixture was prepared by grinding equal quantities of pranlukast and gelatin. In the dissolution testing, the dissolution rate of pranlukast in the suspension of the ground pranlukast-gelatin mixture under conditions of pH 3.0, 5.0 and 7.0 was markedly faster than that in the suspension of pranlukast. According to powder X-ray diffractometry (PXRD) and differential scanning calorimetry (DSC) analysis, the enhanced dissolution rate of pranlukast produced by grinding with gelatin was caused by changing the crystalline state of pranlukast into an amorphous state. In an animal experiment, the bioavailability of pranlukast following oral administration of the ground pranlukast-gelatin mixture to rats was threefold greater than that following administration of pranlukast. In the in vitro permeation experiment, the amount of permeated pranlukast through Caco-2 cell monolayers after application of the ground pranlukast-gelatin mixture was greater than that after application of pranlukast. These results suggest that the enhancement of the gastrointestinal absorption of pranlukast by grinding with gelatin is due to enhancement of the dissolution rate. Grinding a poorly water-soluble drug with gelatin is a useful method of enhancing its gastrointestinal absorption. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:71 / 78
页数:8
相关论文
共 28 条
[1]
Dextran cross-linked gelatin microspheres as a drug delivery system [J].
Cortesi, R ;
Esposito, E ;
Osti, M ;
Squarzoni, G ;
Menegatti, E ;
Davis, SS ;
Nastruzzi, C .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 47 (02) :153-160
[2]
DAUMESNIL R, 2005, P 27 MIN S APSTJ GLO
[3]
Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation [J].
Fukunaka, Y ;
Iwanaga, K ;
Morimoto, K ;
Kakemi, M ;
Tabata, Y .
JOURNAL OF CONTROLLED RELEASE, 2002, 80 (1-3) :333-343
[4]
Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract (Reprinted from Advanced Drug Delivery reviews, vol 25, pg 3-14, 1997) [J].
Hörter, D ;
Dressman, JB .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :75-87
[5]
IMAI T, 1989, CHEM PHARM BULL, V37, P2251
[6]
RAPIDLY ABSORBED SOLID ORAL FORMULATIONS OF IBUPROFEN USING WATER-SOLUBLE GELATIN [J].
IMAI, T ;
KIMURA, S ;
IIJIMA, T ;
MIYOSHI, T ;
UENO, M ;
OTAGIRI, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1990, 42 (09) :615-619
[7]
ISHIDO M, 1993, METABOL DISPOS, V8, P2
[8]
Solubility of drugs in the presence of gelatin: effect of drug lipophilicity and degree of ionization [J].
Kallinteri, P ;
Antimisiaris, SG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 221 (1-2) :219-226
[9]
Gelatin-stabilised microemulsion-based organogels: rheology and application in iontophoretic transdermal drug delivery [J].
Kantaria, S ;
Rees, GD ;
Lawrence, MJ .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (2-3) :355-365
[10]
KIMURA S, 1990, ACTA PHARM NORDICA, V2, P65